|
Frontiers in Antigen Presenting Cell Biology |
|
Published on 7 November 2012 |
Novel Murine Dendritic Cell Lines: A Powerful Auxiliary Tool for Dendritic Cell Research |
Silvia A. Fuertes Marraco, Frédéric Grosjean, Anaïs Duval, Muriel Rosa, Christine Lavanchy, Devika Ashok, Sergio Haller, Luc A. Otten, Quynh-Giao Steiner, Patrick Descombes, Christian A. Luber, Felix Meissner, Matthias Mann, Lajos Szeles, Walter Reith, and Hans Acha-Orbea |
|
Frontiers in Microbial Immunology |
|
Published on 30 October 2012 |
Current understanding of the Trypanosoma cruzi-cardiomyocyte interaction |
Claudia M. Calvet, Tatiana G. Melo, Luciana R. Garzoni, Francisco O. R. Oliveira Jr., Dayse T. Silva Neto, Maria N. S. L., L. Meirelles, and Mirian C. S. Pereira |
Published on 6 November 2012 |
Regulation and use of the extracellular matrix by Trypanosoma cruzi during early infection |
Pius N. Nde, Maria F. Lima, Candice A. Johnson, Siddharth Pratap, and Fernando Villalta |
Published on 8 November 2012 |
Sculpting humoral immunity through dengue vaccination to enhance protective immunity |
Wayne D. Crill, Holly R. Hughes, Nicole B. Trainor, Brent S. Davis, Matt T. Whitney, and Gwong-Jen J. Chang |
|
|
|
Frontiers in Molecular Innate Immunity |
|
Published on 5 November 2012 |
Manipulating the Lewis antigen specificity of the cholesterol-dependent cytolysin lectinolysin |
Sara Lawrence, Susanne Feil, Jessica Holien, Michael Kuiper, Larissa Doughty, Olan Dolezal, Terrence Mulhern, Rodney Tweten, and Michael Parker |
Published on 12 November 2012 |
Abundant neutrophil extracellular traps in thrombus of patient with microscopic polyangiitis |
Daigo Nakazawa, Utano Tomaru, Chiho Yamamoto, Satoshi Jodo, and Akihiro Ishizu |
|
Frontiers in Tumor Immunity |
|
Published on 30 October 2012 |
Targeted DNA vaccines for enhanced induction of idiotype-specific B and T cells |
Agnete B. Fredriksen, Inger Sandlie, and Bjarne Bogen |
Published on 6 November 2012 |
Anti-idiotypic antibodies as cancer vaccines: achievements and future improvements |
Maha Z. Ladjemi |
Published on 8 November 2012 |
Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancer |
Valeria I. Segatori, Ana M. Vazquez, Daniel E. Gomez, Mariano R. Gabri, and Daniel F. Alonso |
Published on 9 November 2012 |
Idiotypes as immunogens: facing the challenge of inducing strong therapeutic immune responses against the variable region of immunoglobulins |
Alejandro López-Requena, Oscar R. Burrone, and Michela Cesco-Gaspere |
|